345 related articles for article (PubMed ID: 22275289)
1. How does the urothelium affect bladder function in health and disease? ICI-RS 2011.
Birder LA; Ruggieri M; Takeda M; van Koeveringe G; Veltkamp S; Korstanje C; Parsons B; Fry CH
Neurourol Urodyn; 2012 Mar; 31(3):293-9. PubMed ID: 22275289
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic modulation of urinary bladder function: multiple targets at multiple levels.
Michel MC
Annu Rev Pharmacol Toxicol; 2015; 55():269-87. PubMed ID: 25251997
[TBL] [Abstract][Full Text] [Related]
3. Urothelial signaling.
Birder L; Andersson KE
Physiol Rev; 2013 Apr; 93(2):653-80. PubMed ID: 23589830
[TBL] [Abstract][Full Text] [Related]
4. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release.
Munoz A; Smith CP; Boone TB; Somogyi GT
Neurochem Int; 2011 Feb; 58(3):295-300. PubMed ID: 21145365
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptor subtypes in the lower urinary tract.
Giglio D; Tobin G
Pharmacology; 2009; 83(5):259-69. PubMed ID: 19295256
[TBL] [Abstract][Full Text] [Related]
6. Highlights in basic autonomic neuroscience: contribution of the urothelium to sensory mechanisms in the urinary bladder.
de Groat WC
Auton Neurosci; 2013 Oct; 177(2):67-71. PubMed ID: 23602550
[TBL] [Abstract][Full Text] [Related]
7. Receptors, channels, and signalling in the urothelial sensory system in the bladder.
Merrill L; Gonzalez EJ; Girard BM; Vizzard MA
Nat Rev Urol; 2016 Apr; 13(4):193-204. PubMed ID: 26926246
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic.
Kumar V; Chapple CR; Rosario D; Tophill PR; Chess-Williams R
Eur Urol; 2010 Jun; 57(6):1087-92. PubMed ID: 20022422
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Mucosa in Normal and Abnormal Bladder Function.
Fry CH; Vahabi B
Basic Clin Pharmacol Toxicol; 2016 Oct; 119 Suppl 3(Suppl 3):57-62. PubMed ID: 27228303
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic perspective on the physiology of the lower urinary tract.
Andersson KE; Hedlund P
Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
[TBL] [Abstract][Full Text] [Related]
11. [Afferent pathways arising from the lower urinary tract. Physiology, pathophysiology, and clinical implications].
Reitz A; Haferkamp A; Hohenfellner M
Urologe A; 2005 Dec; 44(12):1452-7. PubMed ID: 16328211
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effects of Urothelium-related Factors.
Guan NN; Gustafsson LE; Svennersten K
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):220-224. PubMed ID: 28371382
[TBL] [Abstract][Full Text] [Related]
13. What are the origins and relevance of spontaneous bladder contractions? ICI-RS 2017.
Drake MJ; Fry CH; Hashitani H; Kirschner-Hermanns R; Rahnama'i MS; Speich JE; Tomoe H; Kanai AJ; McCloskey KD
Neurourol Urodyn; 2018 Jun; 37(S4):S13-S19. PubMed ID: 29360173
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.
Chess-Williams R
Auton Autacoid Pharmacol; 2002 Jun; 22(3):133-45. PubMed ID: 12452898
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
Ha US; Park EY; Kim JC
Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
[TBL] [Abstract][Full Text] [Related]
17. Beyond neurons: Involvement of urothelial and glial cells in bladder function.
Birder LA; Wolf-Johnston AS; Chib MK; Buffington CA; Roppolo JR; Hanna-Mitchell AT
Neurourol Urodyn; 2010; 29(1):88-96. PubMed ID: 20025015
[TBL] [Abstract][Full Text] [Related]
18. Signalling molecules in the urothelium.
Winder M; Tobin G; Zupančič D; Romih R
Biomed Res Int; 2014; 2014():297295. PubMed ID: 25177686
[TBL] [Abstract][Full Text] [Related]
19. The urothelium in overactive bladder: passive bystander or active participant?
de Groat WC
Urology; 2004 Dec; 64(6 Suppl 1):7-11. PubMed ID: 15621221
[TBL] [Abstract][Full Text] [Related]
20. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder.
Yoshida M; Masunaga K; Nagata T; Yono M; Homma Y
J Pharmacol Sci; 2010; 112(2):128-34. PubMed ID: 20134115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
